Cocrystal Pharma Q4 EPS $(0.44) Beats $(0.60) Estimate

Cocrystal Pharma, Inc. +4.31%

Cocrystal Pharma, Inc.




Cocrystal Pharma (NASDAQ: COCP) reported quarterly losses of $(0.44) per share which beat the analyst consensus estimate of $(0.60) by 26.67 percent. This is a 18.52 percent increase over losses of $(0.54) per share from the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
Also you can contact us via